AVAC Comments to FDA in Support of PrEP Approval
Comments delivered to the FDA’s Antiviral Drugs Advisory Committee (AVDAC) Meeting by Mitchell Warren, Executive Director, AVAC.
Was this content helpful?
Tell us how we can improve the content.
Was this content helpful?
Thank you for your feedback!